Company
MEDiC
Discover the key path to novel cures for cancer
- Status
- Operatingas of 2026-09-17
- Business model
- B2B
Claim, correct or request removal
Record updated 17 September 2026
About
We have combined the power of CRISPR functional genomics with the accuracy/translatability of patient tumor-like cancer models to precisely pinpoint biomarker, synthetic lethality, and resistant mutations for novel cancer drug developments.
Funding snapshot
- Total raised
- $8MSum of rounds, as of 2026-09-17Source (opens in a new tab)
- Latest round
- Seed, $8M2023
Funding rounds
- Seed
- $8M2023, Company stated
Loading relationship preview